Filing Details

This Amendment No. 5 amends and supplements the statement on Schedule 13D originally filed by Lazarus Management Company LLC (“Lazarus Management”), Justin B. Borus, Lazarus Israel Opportunities Fund LLLP (“Lazarus Israel I”), Lazarus Israel Opportunities Fund II LLLP (“Lazarus Israel II”) and Lazarus Investment Partners LLLP (“Lazarus Partners”).  Lazarus Management, Mr. Borus, Lazarus Israel I, Lazarus Israel II and Lazarus Partners are each a “Reporting Person” and are collectively referred to herein as the “Reporting Persons.”  Lazarus Israel I, Lazarus Israel II and Lazarus Partners are collectively referred to as the “Funds.”  A joint filing agreement of the Reporting Persons is attached hereto as Exhibit A.  All capitalized terms contained herein but not otherwise defined shall have the meaning ascribed to such terms in the Schedule 13D.  The information set forth in response to each Item shall be deemed to be a response to all Items where such information is relevant.

Item 4.  Purpose of Transaction.

Item 4 of the Schedule 13D is hereby supplemented by adding the following:

On June 20, 2016, the Reporting Persons contacted the Issuer to express a desire for the Issuer to consider the appointment of an additional director to the Issuer’s board of directors with experience that may be beneficial to the Issuer, although Reporting Persons do not have any definitive plan to change the board of directors of the Issuer.  Specifically, the Reporting Persons provided the Issuer with a recommendation for an additional director for consideration.  The Reporting Persons remain supportive of the Issuer’s management and the Issuer, and expect to continue discussions with the Issuer with respect to the composition of its board of directors, as well as other corporate matters.

Item 5.  Interest in Securities of the Issuer.

(a)-(e)  Reference is made to Items 7, 9, 11 and 13 of pages 2-6 of this Schedule, which items are incorporated by reference.  The securities reported on this Schedule by Lazarus Israel I consist of 42,148,018 Shares and warrants to purchase an additional 12,500,000 Shares (“Warrants”).  The securities reported by Lazarus Israel II consist of 11,843,401 Shares and 2,727,273 Warrants.  The securities reported by Lazarus Partners consist of 8,800,476 Shares and 2,272,728 Warrants.  The securities reported by Lazarus Management and Mr. Borus consists of the sums of the Shares and Warrants held by the Funds.  The calculation of percentage of beneficial ownership in Item 13 of pages 2-6 was calculated based on 219,817,675 Shares outstanding as of May 18, 2016 as reported by the Issuer in its Form 10-Q/A filed on June 13, 2016.

The Reporting Persons effected the transactions in the Issuer’s shares as set forth in Exhibit B since the most recent filing on Schedule 13D on June 14, 2016.

Item 7.  Material to Be Filed as Exhibits.